Ontology highlight
ABSTRACT:
SUBMITTER: Cuneo A
PROVIDER: S-EPMC6585802 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
Cuneo Antonio A Barosi Giovanni G Danesi Romano R Fagiuoli Stefano S Ghia Paolo P Marzano Alfredo A Montillo Marco M Poletti Venerino V Viale Pierluigi P Zinzani Pier Luigi PL
Hematological oncology 20180905 1
The introduction of new therapeutic agents in chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL), including the new kinase inhibitor idelalisib, has changed the therapeutic landscape of these diseases. However, the use of idelalisib is associated with a peculiar profile of side effects, which require an optimization of the current approach to prophylaxis and supportive treatment. Moving from the recognition that the abovementioned issue represents an unmet need in CLL and FL, a mult ...[more]